Graham Lowe
Direktor/Vorstandsmitglied bei Deltex Medical Ltd.
Aktive Positionen von Graham Lowe
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Direktor/Vorstandsmitglied | 01.11.2004 | - |
Karriereverlauf von Graham Lowe
Ehemalige bekannte Positionen von Graham Lowe
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DELTEX MEDICAL GROUP PLC | Geschäftsführer | 01.01.2002 | - |
Vertrieb & Marketing | 01.01.2002 | 01.01.2016 |
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
- Börse
- Insiders
- Graham Lowe
- Erfahrung